Disease/Infection News

RSS

Brain metabolic changes associated with loss of smell in COVID-19

A recent study detailed in a preprint paper published in medRxiv, researchers from Belgium, discuss how they investigated possible central nervous system (CNS) involvement in COVID-19 patients with a sudden loss of smell using a hybrid positron emission tomography (PET)-magnetic resonance imaging (MRI) system (PET-MR).

21 Oct 2020

Mass screening strategy for Covid-19 could be cheaper than individual testing, study suggests

Using a new mathematical approach to screen large groups for Covid-19 could be around 20 times cheaper than individual testing, a study suggests.

21 Oct 2020

Hydroxychloroquine does not prevent COVID-19 in health care workers, trial shows

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.

21 Oct 2020

Dietary supplement represents an innovative strategy to help in the fight against SARS-CoV-2

SPIN (SPermidin and eugenol INtegrator for contrasting incidence of coronavirus in EU population) is a European project powered by EIT Food that is currently developing a dietary supplement supporting the function of the immune system in the fight against SARS-CoV-2 infections in population at high risk.

21 Oct 2020

Pastoral care helped to mitigate COVID-19 impact among the elderly

Volunteers from the Catholic Church in Brazil helped to mitigate the impact of COVID-19 among the elderly, a new study shows.

21 Oct 2020

SARS-CoV-2 mutations possibly making virus less virulent

In their bioRxiv* preprint paper, the researchers focus on mapping the clade-specific mutations' effects on the protein structures' conformation and stability. They identified the mutations in the set of seven proteins - orf8, nsp2, nsp4, nsp6, nucleocapsid protein (N), and Spike protein (S).

21 Oct 2020

UK researchers to investigate the neurological and neuropsychiatric effects of COVID-19

A grant worth over two million pounds has been awarded to clinical researchers from the University of Liverpool and King's College London to investigate the neurological and neuropsychiatric effects of COVID-19.

21 Oct 2020

Researchers receive more than $1 million NIH grants for COVID-19 pandemic-related projects

Researchers in Northern Arizona University's Center for Health Equity Research and the Southwest Health Equity Research Collaborative recently received four grants totaling more than $1 million from the National Institutes of Health for projects related to the COVID-19 pandemic.

21 Oct 2020

"Immunological imprinting" could influence antibody response to COVID-19

Researchers in the United States and Spain have shown that prior exposure to seasonal coronaviruses may influence antibody responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19).

21 Oct 2020

More than 2.5 million person-years of life lost in US due to COVID-19

In a recently published study, researcher Stephen Elledge from Harvard Medical School has described converting the coronavirus disease (COVID-19) death toll from individual deaths to “person-years” lost in order to provide a more accurate picture of the pandemic’s toll on the population.

21 Oct 2020

Eliminating the Cold Chain with COVID-19 Molecular Transport Media

In this interview, Rebekah Stibbs from EKF Diagnostics talks to News-Medical about eliminating the cold chain with COVID-19 molecular transport media.

From EKF Diagnostics 21 Oct 2020

Study analyzes the effect of political factors on COVID-19 vaccine acceptance among the public

If an initial COVID-19 vaccine is about as effective as a flu shot, uptake by the American public may fall far short of the 70% level needed to achieve herd immunity, new Cornell research suggests.

21 Oct 2020

Spike protein of SARS-CoV-2 virus identifies and binds neuropilin-1 on human cells to infect them

Helping to explain what makes SARS-CoV-2 so capable of infecting human cells, researchers in two independent studies discovered that the virus's spike protein recognizes and binds a protein on the human cell surface called neuropilin-1.

21 Oct 2020

Breakthrough 25-minute COVID-19 test reaches final stages of clinical validation

A BREAKTHROUGH test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation by British biotech firm MicrosensDx.

21 Oct 2020

Study indicates the relationship between SARS-CoV-2 viral infection and diabetes

It has recently been described that infection by some enteroviruses - a genus of viruses that commonly cause diseases of varying severity - could potentially trigger diabetes, although its direct effect 'in vivo' as well as its mechanism of action at the molecular level were unknown.

21 Oct 2020

Increasing levels of light pollution could impact transmission of diseases through mosquitoes

Artificial light abnormally increases mosquito biting behavior at night in a species that typically prefers to bite people during the day, according to research from the University of Notre Dame that was published in The American Journal of Tropical Medicine and Hygiene.

21 Oct 2020

Researchers conduct review on viral shedding of SARS-CoV-2

A review of dozens of studies by researchers at Oregon Health & Science University and Oregon State University suggests that people may shed virus for prolonged periods, but those with mild or no symptoms may be infectious for no more than about 10 days.

21 Oct 2020

New research highlights potential global hesitancy to accept a COVID-19 vaccine

A research team from the City University of New York Graduate School of Public Health and Health Policy, the Barcelona Institute for Global Health, the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, and Georgetown University Law School announced today that Nature Medicine has published their research revealing potential global hesitancy to accept a COVID-19 vaccine.

21 Oct 2020

SARS-CoV-2 hijacks mitochondria

An important phase of the viral protein translation relies on the mitochondrial translation machinery. Towards this goal, the molecular mechanism involved in the SARS-CoV-2 entry into human cells is studied by Zhenguo Cheng et al.

21 Oct 2020

Study shows SARS-CoV-2 uses a receptor to efficiently infect human cells

To efficiently infect human cells, SARS-CoV-2, the virus that causes COVID-19, is able to use a receptor called Neuropilin-1, which is very abundant in many human tissues including the respiratory tract, blood vessels and neurons.

21 Oct 2020

Disease/Infection News

Brain metabolic changes associated with loss of smell in COVID-19

Mass screening strategy for Covid-19 could be cheaper than individual testing, study suggests

Hydroxychloroquine does not prevent COVID-19 in health care workers, trial shows

Dietary supplement represents an innovative strategy to help in the fight against SARS-CoV-2

Pastoral care helped to mitigate COVID-19 impact among the elderly

SARS-CoV-2 mutations possibly making virus less virulent

UK researchers to investigate the neurological and neuropsychiatric effects of COVID-19

Researchers receive more than $1 million NIH grants for COVID-19 pandemic-related projects

"Immunological imprinting" could influence antibody response to COVID-19

More than 2.5 million person-years of life lost in US due to COVID-19

Eliminating the Cold Chain with COVID-19 Molecular Transport Media

Study analyzes the effect of political factors on COVID-19 vaccine acceptance among the public

Spike protein of SARS-CoV-2 virus identifies and binds neuropilin-1 on human cells to infect them

Breakthrough 25-minute COVID-19 test reaches final stages of clinical validation

Study indicates the relationship between SARS-CoV-2 viral infection and diabetes

Increasing levels of light pollution could impact transmission of diseases through mosquitoes

Researchers conduct review on viral shedding of SARS-CoV-2

New research highlights potential global hesitancy to accept a COVID-19 vaccine

SARS-CoV-2 hijacks mitochondria

Study shows SARS-CoV-2 uses a receptor to efficiently infect human cells

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News